SCHEMBL97689

SCHEMBL97689

NCCCC[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1960836 0.97 DNM1 (0.50)
SCHEMBL8811124 0.97 DNM1 (0.50)
SCHEMBL186389 0.97
SCHEMBL465588 0.97 DNM1 (0.50)
SCHEMBL98073 0.97
SCHEMBL8812186 0.97 DNM1 (0.50)
SCHEMBL8812602 0.97 DNM1 (0.50)
SCHEMBL381495 0.97 DNM1 (0.50)
SCHEMBL666946 0.97 DNM1 (0.50)
SCHEMBL666569 0.97 DNM1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 692 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118021978-A GHRH antagonists for use in methods of treating sarcoidosis 迈阿密大学 2024-05-14 CN claimed
US-11965039-B2 Compstatin analogues and their medical uses ZP SPV 3 K/S (DK) 2024-04-23 US claimed
EP-4331674-A2 GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS University of Miami (US) 2024-03-06 EP claimed
EP-4272751-A2 COMPSTATIN ANALOGUES AND THEIR MEDICAL USES ZP SPV 3 K/S (DK) 2023-11-08 EP claimed
EP-3999095-B1 GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS UNIV MIAMI (US) 2023-09-13 EP claimed
US-20230203558-A1 DIAGNOSTIC PEPTIDE FOR USE IN A METHOD OF DIAGNOSIS OF VIRAL INFECTION, KIT AND SYSTEM ORIGINAL G B.V. (NL) 2023-06-29 US claimed
US-20230192770-A1 COMPSTATIN ANALOGUES AND THEIR MEDICAL USES ZEALAND PHARMA A/S (DK) 2023-06-22 US claimed
WO-2023064152-A1 TRICYCLIC SULFAMIDES AND SULTAMS MERCK SHARP & DOHME LLC (US) 2023-04-20 WO claimed
EP-4127206-A1 DIAGNOSTIC PEPTIDE FOR USE IN A METHOD OF DIAGNOSIS OF VIRAL INFECTION, KIT AND SYSTEM Original G B.V. (NL) 2023-02-08 EP claimed
CN-115362262-A Diagnostic peptides for use in methods, kits and systems for diagnosing viral infections 奥里基诺G有限公司 2022-11-18 CN claimed
WO-1995004540-A1 N-TERMINUS MODIFIED ANALOGS OF LHRH ABBOTT LABORATORIES (US) 1995-02-16 WO claimed
WO-1994013313-A1 6-POSITION MODIFIED DECAPEPTIDE LHRH ANTAGONISTS ABBOTT LABORATORIES (US) 1994-06-23 WO claimed
EP-0410278-B1 Renin inhibiting aminooligohydroxy-derivatives HOECHST AG (DE) 1994-01-19 EP claimed
EP-0255082-B1 Renin-inhibiting di- and tripeptides, methods for their production, drugs containing them, and their use HOECHST AG (DE) 1993-12-01 EP claimed
EP-0410278-A1 Renin inhibiting aminooligohydroxy-derivatives HOECHST AKTIENGESELLSCHAFT (DE) 1991-01-30 EP claimed
EP-0394829-A1 Renin-inhibiting dipeptides, process to synthetize them, compositions containing them and their use HOECHST AKTIENGESELLSCHAFT (DE) 1990-10-31 EP claimed
EP-0334244-A2 Bradykinin Antagonist Peptides THE PROCTER & GAMBLE COMPANY (US) 1989-09-27 EP claimed
US-4855286-A HYPOTENSIVE AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 1989-08-08 US claimed
EP-0255082-A2 Renin-inhibiting di- and tripeptides, methods for their production, drugs containing them, and their use HOECHST AKTIENGESELLSCHAFT (DE) 1988-02-03 EP claimed
EP-0239874-A2 Substituted derivatives of 4-amino-3-hydroxy-butyric acid, process for their production, medicines containing them, and their application HOECHST AKTIENGESELLSCHAFT (DE) 1987-10-07 EP claimed